secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2022-11-28T23:59:59+00:00
Accession:  0001640334-22-002518
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience replaces auditor; Davidson declines re-election, MaloneBailey appointed
--------------------------------------------------------------------------------

- Davidson & Company LLP will not stand for re-election after completing FY2022 audit.
- No disagreements or reportable events with Davidson during FY2022 and FY2021.
- Audit Committee selected MaloneBailey LLP as new independent auditor effective Nov 25, 2022.
- No prior consultations with MaloneBailey regarding accounting principles or audit opinions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033422002518/0001640334-22-002518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033422002518/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-22-002518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer